News & Updates
Filter by Specialty:
Tirzepatide beneficial for shedding pounds in obese adults
Once-weekly treatment with tirzepatide in adults with obesity appears to yield substantial and sustained reductions in body weight, according to the phase III SURMOUNT-1 trial.
Tirzepatide beneficial for shedding pounds in obese adults
21 Jul 2022
Real-world studies demonstrate TAF efficacy and safety in chronic hep B
Treatment with tenofovir alafenamide (TAF) results in similar virological response compared with tenofovir disoproxil fumarate (TDF) in treatment-naïve patients with chronic hepatitis B (CHB), according to a real-world study from Korea presented at ILC 2022.
Real-world studies demonstrate TAF efficacy and safety in chronic hep B
20 Jul 2022
Smoking, comorbidities, EAMs up death risk in hospitalized ankylosing spondylitis patients
Smoking, extra-articular manifestations (EAMs), and comorbidities are all associated with a higher risk of all-cause mortality in hospitalized patients with ankylosing spondylitis (AS) than those in the comparison cohort, reports a study.
Smoking, comorbidities, EAMs up death risk in hospitalized ankylosing spondylitis patients
20 Jul 2022
Older age, lower BMI, seropositivity tied to RA-related bronchiectasis
Isolated bronchiectasis (BR) in rheumatoid arthritis (RA) that is not caused by interstitial lung disease (ILD) is associated with seropositivity, older age at RA diagnosis, and lower body mass index (BMI) at RA onset, a recent study has found.
Older age, lower BMI, seropositivity tied to RA-related bronchiectasis
20 Jul 2022
Diuretics do not reduce tissue sodium in patients with early hypertension
In patients with pre- or mild hypertension, sodium content in the skin and muscles did not decrease with dietary salt restriction or diuretic intervention over a period of 8 weeks, a study has shown.
